gdme0059rdb europe neurology devices market outlook to 2017 · 4.3.5 neurosurgical products,...

Europe Neurology Devices Market Outlook to 2017 GDME0059RDB /Published March 2011

© GlobalData. This report is a licensed product and is not to be photocopied

Europe Neurology Devices Market Outlook to 2017 Sample Pages

Reference Code: GDME0059RDB

Publication Date: March 2011

Table of Contents



1 Table of Contents

1 Table of Contents 2

1.1 List of Tables 8

1.2 List of Figures 11

2 Introduction 13

2.1 What is This Report About? 13

3 Neurology Devices in Europe 14

3.1 Neurology Devices Cross Country Comparison, Revenue ($m), 2003-2017 14

3.2 Neurology Devices, Europe, Overall Revenue ($m), 2003-2017 15

3.3 Neurology Devices, Europe, Category Volume (Units), 2003-2017 21

3.4 Neurology Devices, Europe, Company share (2009-2010) 26

4 Neurology Devices In Germany 28

4.1 Neurology Devices, Germany, Overall Revenue ($m), 2003-2017 28

4.2 Neurology Devices, Germany, Category Volume (Units), 2003-2017 34

4.3 Neurology Devices, Germany, Distribution Share (2009-2010) 39 4.3.1 CSF Management, Germany, Distribution Share (2009-2010) 39 4.3.2 Interventional Neurology, Germany, Distribution Share (2009-2010) 39 4.3.3 Neurological Diagnostic Equipment, Germany, Distribution Share (2009-2010) 40 4.3.4 Neurostimulation Devices, Germany, Distribution Share (2009-2010) 40 4.3.5 Neurosurgical Products, Germany, Distribution Share (2009-2010) 41 4.3.6 Radiosurgery, Germany, Distribution Share (2009-2010) 41

4.4 Neurology Devices, Germany, Company Share (2009-2010) 42 4.4.1 Neurology Devices, Germany, Company Share (2009-2010) 42 4.4.2 CSF Management, Germany, Company Share (2009-2010) 44 4.4.3 Interventional Neurology, Germany, Company Share (2009-2010) 46 4.4.4 Neurological Diagnostic Equipment, Germany, Company Share (2009-2010) 48 4.4.5 Neurostimulation Devices, Germany, Company Share (2009-2010) 50 4.4.6 Neurosurgical Products, Germany, Company Share (2009-2010) 51 4.4.7 Radiosurgery, Germany, Company Share (2009-2010) 52

Table of Contents



5 Neurology Devices In France 53

5.1 Neurology Devices, France, Overall Revenue ($m), 2003-2017 53

5.2 Neurology Devices, France, Category Volume (Units), 2003-2017 59

5.3 Neurology Devices, France, Distribution Share (2009-2010) 64 5.3.1 CSF Management, France, Distribution Share (2009-2010) 64 5.3.2 Interventional Neurology, France, Distribution Share (2009-2010) 64 5.3.3 Neurological Diagnostic Equipment, France, Distribution Share (2009-2010) 65 5.3.4 Neurostimulation Devices, France, Distribution Share (2009-2010) 65 5.3.5 Neurosurgical Products, France, Distribution Share (2009-2010) 66 5.3.6 Radiosurgery, France, Distribution Share (2009-2010) 66

5.4 Neurology Devices, France, Company Share (2009-2010) 67 5.4.1 Neurology Devices, France, Company Share (2009-2010) 67 5.4.2 CSF Management, France, Company Share (2009-2010) 69 5.4.3 Interventional Neurology, France, Company Share (2009-2010) 71 5.4.4 Neurological Diagnostic Equipment, France, Company Share (2009-2010) 73 5.4.5 Neurostimulation Devices, France, Company Share (2009-2010) 75 5.4.6 Neurosurgical Products, France, Company Share (2009-2010) 77 5.4.7 Radiosurgery, France, Company Share (2010) 78

6 Neurology Devices In United Kingdom 79

6.1 Neurology Devices, United Kingdom, Overall Revenue ($m), 2003-2017 79

6.2 Neurology Devices, United Kingdom, Category Volume (Units), 2003-2017 85

6.3 Neurology Devices, United Kingdom, Distribution Share (2009-2010) 90 6.3.1 CSF Management, United Kingdom, Distribution Share (2009-2010) 90 6.3.2 Interventional Neurology, United Kingdom, Distribution Share (2009-2010) 90 6.3.3 Neurological Diagnostic Equipment, United Kingdom, Distribution Share (2009-2010) 91 6.3.4 Neurostimulation Devices, United Kingdom, Distribution Share (2009-2010) 91 6.3.5 Neurosurgical Products, United Kingdom, Distribution Share (2009-2010) 92 6.3.6 Radiosurgery, United Kingdom, Distribution Share (2009-2010) 92

6.4 Neurology Devices, United Kingdom, Company Share (2009-2010) 93 6.4.1 Neurology Devices, United Kingdom, Company Share (2009-2010) 93 6.4.2 CSF Management, United Kingdom, Company Share (2009-2010) 95 6.4.3 Interventional Neurology, United Kingdom, Company Share (2009-2010) 96 6.4.4 Neurological Diagnostic Equipment, United Kingdom, Company Share (2009-2010) 98 6.4.5 Neurostimulation Devices, United Kingdom, Company Share (2009-2010) 100 6.4.6 Neurosurgical Products, United Kingdom, Company Share (2009-2010) 101

Table of Contents



6.4.7 Radiosurgery, United Kingdom, Company Share (2009-2010) 102

7 Neurology Devices In Italy 103

7.1 Neurology Devices, Italy, Overall Revenue ($m), 2003-2017 103

7.2 Neurology Devices, Italy, Category Volume (Units), 2003-2017 109

7.3 Neurology Devices, Italy, Distribution Share (2009-2010) 114 7.3.1 CSF Management, Italy, Distribution Share (2009-2010) 114 7.3.2 Interventional Neurology, Italy, Distribution Share (2009-2010) 114 7.3.3 Neurological Diagnostic Equipment, Italy, Distribution Share (2009-2010) 115 7.3.4 Neurostimulation Devices, Italy, Distribution Share (2009-2010) 115 7.3.5 Neurosurgical Products, Italy, Distribution Share (2009-2010) 116 7.3.6 Radiosurgery, Italy, Distribution Share (2009-2010) 116

7.4 Neurology Devices, Italy, Company Share (2009-2010) 117 7.4.1 Neurology Devices, Italy, Company Share (2009-2010) 117 7.4.2 CSF Management, Italy, Company Share (2009-2010) 119 7.4.3 Interventional Neurology, Italy, Company Share (2009-2010) 121 7.4.4 Neurological Diagnostic Equipment, Italy, Company Share (2009-2010) 123 7.4.5 Neurostimulation Devices, Italy, Company Share (2009-2010) 125 7.4.6 Neurosurgical Products, Italy, Company Share (2009-2010) 126 7.4.7 Radiosurgery, Italy, Company Share (2009-2010) 127

8 Neurology Devices In Spain 128

8.1 Neurology Devices, Spain, Overall Revenue ($m), 2003-2017 128

8.2 Neurology Devices, Spain, Category Volume (Units), 2003-2017 134

8.3 Neurology Devices, Spain, Distribution Share (2009-2010) 139 8.3.1 CSF Management, Spain, Distribution Share (2009-2010) 139 8.3.2 Interventional Neurology, Spain, Distribution Share (2009-2010) 139 8.3.3 Neurological Diagnostic Equipment, Spain, Distribution Share (2009-2010) 140 8.3.4 Neurostimulation Devices, Spain, Distribution Share (2009-2010) 140 8.3.5 Neurosurgical Products, Spain, Distribution Share (2009-2010) 141 8.3.6 Radiosurgery, Spain, Distribution Share (2009) 141

8.4 Neurology Devices, Spain, Company Share (2009-2010) 142 8.4.1 Neurology Devices, Spain, Company Share (2009-2010) 142 8.4.2 CSF Management, Spain, Company Share (2009-2010) 144 8.4.3 Interventional Neurology, Spain, Company Share (2009-2010) 145 8.4.4 Neurological Diagnostic Equipment, Spain, Company Share (2009-2010) 147

Table of Contents



8.4.5 Neurostimulation Devices, Spain, Company Share (2009-2010) 149 8.4.6 Neurosurgical Products, Spain, Company Share (2009-2010) 151 8.4.7 Radiosurgery, Spain, Company Share (2009) 152

9 Overview of Key Companies in Europe Neurology Devices Market 153

9.1 Medtronic, Inc. 153 9.1.1 Company Overview 153 9.1.2 Share in the Europe Neurology Devices Market 153

9.2 St. Jude Medical, Inc. 154 9.2.1 Company Overview 154 9.2.2 Share in the Europe Neurology Devices Market 154

9.3 B. Braun Melsungen AG 155 9.3.1 Company Overview 155 9.3.2 Share in the Europe Neurology Devices Market 155

9.4 Boston Scientific Corporation 156 9.4.1 Company Overview 156 9.4.2 Share in the Europe Neurology Devices Market 156

9.5 Cadwell Laboratories, Inc. 157 9.5.1 Company Overview 157 9.5.2 Share in the Europe Neurology Devices Market 157

9.6 Accuray Incorporated 158 9.6.1 Company Overview 158 9.6.2 Share in the Europe Neurology Devices Market 158

9.7 DePuy, Inc. 159 9.7.1 Company Overview 159

9.8 Covidien plc 159 9.8.1 Company Overview 159

9.9 Terumo Corporation 159 9.9.1 Company Overview 159

9.10 Elekta AB 160 9.10.1 Company Overview 160

9.11 Cyberonics, Inc. 160 9.11.1 Company Overview 160

Table of Contents



9.12 Micrus Endovascular Corporation 161 9.12.1 Company Overview 161

9.13 CareFusion Corporation 161 9.13.1 Company Overview 161

9.14 Integra LifeSciences Holdings Corporation 162 9.14.1 Company Overview 162

9.15 Nihon Kohden Corporation 162 9.15.1 Company Overview 162

9.16 Micromed S.p.A 163 9.16.1 Company Overview 163

9.17 ev3 Inc. 163 9.17.1 Company Overview 163

9.18 Natus Medical Incorporated 163 9.18.1 Company Overview 163

9.19 Sophysa S.A. 164 9.19.1 Company Overview 164

9.20 KARL STORZ GmbH & Co. KG 164 9.20.1 Company Overview 164

10 Neurology Devices Market Pipeline Products 165

11 Financial Deals Landscape 166

11.1 Acquisition 166 11.1.1 Vycor Medical Completes Acquisition of NovaVision 166 11.1.2 VELUX STIFTUNG Acquires Minority Stake In NeMoDevices 167

11.2 Partnerships 168 11.2.1 NeuroWave Enters Into Distribution Agreement With CareFusion 168 11.2.2 Laboratorios Rubio Enters Into Distribution Agreement With AB-Biotics 169

12 Recent Developments 170

12.1 Government and Public Interest 170 12.1.1 Nov 10, 2010: Brunel Professor Develops 30-Second Test To Detect Early Alzheimer's 170 12.1.2 Aug 10, 2010: Brain Scan Diagnoses Autism: Institute Of Psychiatry Scientists 170

Table of Contents



12.1.3 Jun 30, 2010: Tests Could Help Predict Alzheimer’s Disease Progression: Alzheimer's Society 171 12.1.4 Apr 29, 2010: Surgery For Deep Brain Stimulation Benefits Patients With Parkinson's Disease: University Of Birmingham Study 171 12.1.5 Mar 23, 2010: Blood Flow In The Brain Can Now Be Measured In Real Time 172

12.2 Product News 173 12.2.1 Jul 15, 2010: Elekta to Highlight Intelligent Cancer Management Solutions At 2010 AAPM Annual Meeting 173 12.2.2 Apr 23, 2010: Karolinska University Hospital Acquires Leksell Gamma Knife Perfexion To Expand Radiosurgery Versatility, Efficiency In Brain Cancer Therapy 174

13 Appendix 175

13.1 Definitions of Markets Covered in the Report 176 13.1.1 Neurology Devices 176

13.2 Research Methodology 177

13.3 Secondary Research 177

13.4 Primary Research 178

13.5 Models 178

13.6 Forecasts 179

13.7 Expert Panels 179

13.8 GlobalData Consulting 179

13.9 Currency Conversion 180

13.10 Contact Us 180

13.11 Disclaimer 180

Table of Contents



1.1 List of Tables Table 1: Neurology Devices, Cross Country Comparison, Revenue ($m), 2003-2017 ........................................................14 Table 2: Neurology Devices, Europe, Overall Revenue ($m), 2003-2017..............................................................................15 Table 3: Neurology Devices, Europe, Cross-Category Analysis, 2003-2017 .............................................................................16 Table 4: Neurology Devices, Europe, Overall Revenue ($m), Historic, 2003-2010 ..............................................................18 Table 5: Neurology Devices, Europe, Overall Revenue ($m), Forecast, 2010-2017............................................................20 Table 6: Neurology Devices, Europe, Category Volume (Units), 2003-2017 .........................................................................21 Table 7: Neurology Devices, Europe, Category Volume (Units), Historic, 2003-2010 .........................................................23 Table 8: Neurology Devices, Europe, Category Volume (Units), Forecast, 2010-2017 .......................................................25 Table 9: Neurology Devices, Europe, Company share by Revenue ($m), 2009-2010 ........................................................27 Table 10: Neurology Devices, Germany, Overall Revenue ($m), 2003-2017 ........................................................................29 Table 11: Neurology Devices, Germany, Overall Revenue ($m), Historic, 2003-2010 ........................................................31 Table 12: Neurology Devices, Germany, Overall Revenue ($m), Forecast, 2010-2017......................................................33 Table 13: Neurology Devices, Germany, Category Volume (Units), 2003-2017 ...................................................................34 Table 14: Neurology Devices, Germany, Category Volume (Units), Historic, 2003-2010 ...................................................36 Table 15: Neurology Devices, Germany, Category Volume (Units), Forecast, 2010-2017 .................................................38 Table 16: CSF Management, Germany, Distribution Share by Revenue ($m), 2009-2010 ................................................39 Table 17: Interventional Neurology, Germany, Distribution Share by Revenue ($m), 2009-2010 .....................................39 Table 18: Neurological Diagnostic Equipment, Germany, Distribution Share by Revenue ($m), 2009-2010 ..................40 Table 19: Neurostimulation Devices, Germany, Distribution Share by Revenue ($m), 2009-2010 ...................................40 Table 20: Neurosurgical Products, Germany, Distribution Share by Revenue ($m), 2009-2010 .......................................41 Table 21: Radiosurgery, Germany, Distribution Share by Revenue ($m), 2009-2010 .........................................................41 Table 22: Neurology Devices, Germany, Company Share by Revenue ($m), 2009-2010 ..................................................43 Table 23: CSF Management, Germany, Company Share by Revenue ($m), 2009-2010 ...................................................45 Table 24: Interventional Neurology, Germany, Company Share by Revenue ($m), 2009-2010 ........................................47 Table 25: Neurological Diagnostic Equipment, Germany, Company Share by Revenue ($m), 2009-2010 .....................49 Table 26: Neurostimulation Devices, Germany, Company Share by Revenue ($m), 2009-2010 ......................................50 Table 27: Neurosurgical Products, Germany, Company Share by Revenue ($m), 2009-2010 ..........................................51 Table 28: Radiosurgery, Germany, Company Share by Revenue ($m), 2009-2010 ............................................................52 Table 29: Neurology Devices, France, Overall Revenue ($m), 2003-2017 ............................................................................54 Table 30: Neurology Devices, France, Overall Revenue ($m), Historic, 2003-2010 ............................................................56 Table 31: Neurology Devices, France, Overall Revenue ($m), Forecast, 2010-2017 ..........................................................58 Table 32: Neurology Devices, France, Category Volume (Units), 2003-2017 .......................................................................59 Table 33: Neurology Devices, France, Category Volume (Units), Historic, 2003-2010 .......................................................61 Table 34: Neurology Devices, France, Category Volume (Units), Forecast, 2010-2017 .....................................................63 Table 35: CSF Management, France, Distribution Share by Revenue ($m), 2009-2010 ....................................................64 Table 36: Interventional Neurology, France, Distribution Share by Revenue ($m), 2009-2010 .........................................64 Table 37: Neurological Diagnostic Equipment, France, Distribution Share by Revenue ($m), 2009-2010 ......................65 Table 38: Neurostimulation Devices, France, Distribution Share by Revenue ($m), 2009-2010 .......................................65

Table of Contents



Table 39: Neurosurgical Products, France, Distribution Share by Revenue ($m), 2009-2010 ...........................................66 Table 40: Radiosurgery, France, Distribution Share by Revenue ($m), 2010 .......................................................................66 Table 41: Neurology Devices, France, Company Share by Revenue ($m), 2009-2010 ......................................................68 Table 42: CSF Management, France, Company Share by Revenue ($m), 2009-2010 .......................................................70 Table 43: Interventional Neurology, France, Company Share by Revenue ($m), 2009-2010 ............................................72 Table 44: Neurological Diagnostic Equipment, France, Company Share by Revenue ($m), 2009-2010 .........................74 Table 45: Neurostimulation Devices, France, Company Share by Revenue ($m), 2009-2010 ..........................................76 Table 46: Neurosurgical Products, France, Company Share by Revenue ($m), 2009-2010 ..............................................77 Table 47: Radiosurgery, France, Company Share by Revenue ($m), 2010 ..........................................................................78 Table 48: Neurology Devices, United Kingdom, Overall Revenue ($m), 2003-2017............................................................80 Table 49: Neurology Devices, United Kingdom, Overall Revenue ($m), Historic, 2003-2010 ............................................82 Table 50: Neurology Devices, United Kingdom, Overall Revenue ($m), Forecast, 2010-2017..........................................84 Table 51: Neurology Devices, United Kingdom, Category Volume (Units), 2003-2017 .......................................................85 Table 52: Neurology Devices, United Kingdom, Category Volume (Units), Historic, 2003-2010 .......................................87 Table 53: Neurology Devices, United Kingdom, Category Volume (Units), Forecast, 2010-2017 .....................................89 Table 54: CSF Management, United Kingdom, Distribution Share by Revenue ($m), 2009-2010 ....................................90 Table 55: Interventional Neurology, United Kingdom, Distribution Share by Revenue ($m), 2009-2010 .........................90 Table 56: Neurological Diagnostic Equipment, United Kingdom, Distribution Share by Revenue ($m), 2009-2010 ......91 Table 57: Neurostimulation Devices, United Kingdom, Distribution Share by Revenue ($m), 2009-2010 .......................91 Table 58: Neurosurgical Products, United Kingdom, Distribution Share by Revenue ($m), 2009-2010...........................92 Table 59: Radiosurgery, United Kingdom, Distribution Share by Revenue ($m), 2009-2010.............................................92 Table 60: Neurology Devices, United Kingdom, Company Share by Revenue ($m), 2009-2010 ......................................94 Table 61: CSF Management, United Kingdom, Company Share by Revenue ($m), 2009-2010 .......................................95 Table 62: Interventional Neurology, United Kingdom, Company Share by Revenue ($m), 2009-2010 ............................97 Table 63: Neurological Diagnostic Equipment, United Kingdom, Company Share by Revenue ($m), 2009-2010.........99 Table 64: Neurostimulation Devices, United Kingdom, Company Share by Revenue ($m), 2009-2010 ........................100 Table 65: Neurosurgical Products, United Kingdom, Company Share by Revenue ($m), 2009-2010............................101 Table 66: Radiosurgery, United Kingdom, Company Share by Revenue ($m), 2009-2010..............................................102 Table 67: Neurology Devices, Italy, Overall Revenue ($m), 2003-2017 ...............................................................................104 Table 68: Neurology Devices, Italy, Overall Revenue ($m), Historic, 2003-2010 ...............................................................106 Table 69: Neurology Devices, Italy, Overall Revenue ($m), Forecast, 2010-2017 .............................................................108 Table 70: Neurology Devices, Italy, Category Volume (Units), 2003-2017 ..........................................................................109 Table 71: Neurology Devices, Italy, Category Volume (Units), Historic, 2003-2010...........................................................111 Table 72: Neurology Devices, Italy, Category Volume (Units), Forecast, 2010-2017 ........................................................113 Table 73: CSF Management, Italy, Distribution Share by Revenue ($m), 2009-2010 .......................................................114 Table 74: Interventional Neurology, Italy, Distribution Share by Revenue ($m), 2009-2010 ............................................114 Table 75: Neurological Diagnostic Equipment, Italy, Distribution Share by Revenue ($m), 2009-2010 .........................115 Table 76: Neurostimulation Devices, Italy, Distribution Share by Revenue ($m), 2009-2010 ..........................................115 Table 77: Neurosurgical Products, Italy, Distribution Share by Revenue ($m), 2009-2010 ..............................................116 Table 78: Radiosurgery, Italy, Distribution Share by Revenue ($m), 2009-2010 ................................................................116

Table of Contents


© GlobalData. This report is a licensed product and is not to be photocopied Pag e 10

Table 79: Neurology Devices, Italy, Company Share by Revenue ($m), 2009-2010 .........................................................118 Table 80: CSF Management, Italy, Company Share by Revenue ($m), 2009-2010 ..........................................................120 Table 81: Interventional Neurology, Italy, Company Share by Revenue ($m), 2009-2010 ...............................................122 Table 82: Neurological Diagnostic Equipment, Italy, Company Share by Revenue ($m), 2009-2010 ............................124 Table 83: Neurostimulation Devices, Italy, Company Share by Revenue ($m), 2009-2010 .............................................125 Table 84: Neurosurgical Products, Italy, Company Share by Revenue ($m), 2009-2010 .................................................126 Table 85: Radiosurgery, Italy, Company Share by Revenue ($m), 2009-2010 ...................................................................127 Table 86: Neurology Devices, Spain, Overall Revenue ($m), 2003-2017 ............................................................................129 Table 87: Neurology Devices, Spain, Overall Revenue ($m), Historic, 2003-2010 ............................................................131 Table 88: Neurology Devices, Spain, Overall Revenue ($m), Forecast, 2010-2017 ..........................................................133 Table 89: Neurology Devices, Spain, Category Volume (Units), 2003-2017 .......................................................................134 Table 90: Neurology Devices, Spain, Category Volume (Units), Historic, 2003-2010........................................................136 Table 91: Neurology Devices, Spain, Category Volume (Units), Forecast, 2010-2017 .....................................................138 Table 92: CSF Management, Spain, Distribution Share by Revenue ($m), 2009-2010 ....................................................139 Table 93: Interventional Neurology, Spain, Distribution Share by Revenue ($m), 2009-2010 .........................................139 Table 94: Neurological Diagnostic Equipment, Spain, Distribution Share by Revenue ($m), 2009-2010 ......................140 Table 95: Neurostimulation Devices, Spain, Distribution Share by Revenue ($m), 2009-2010 .......................................140 Table 96: Neurosurgical Products, Spain, Distribution Share by Revenue ($m), 2009-2010 ...........................................141 Table 97: Radiosurgery, Spain, Distribution Share by Revenue ($m), 2009........................................................................141 Table 98: Neurology Devices, Spain, Company Share by Revenue ($m), 2009-2010 ......................................................143 Table 99: CSF Management, Spain, Company Share by Revenue ($m), 2009-2010 .......................................................144 Table 100: Interventional Neurology, Spain, Company Share by Revenue ($m), 2009-2010 ..........................................146 Table 101: Neurological Diagnostic Equipment, Spain, Company Share by Revenue ($m), 2009-2010 .......................148 Table 102: Neurostimulation Devices, Spain, Company Share by Revenue ($m), 2009-2010 ........................................150 Table 103: Neurosurgical Products, Spain, Company Share by Revenue ($m), 2009-2010 ............................................151 Table 104: Radiosurgery, Spain, Company Share by Revenue ($m), 2009 ........................................................................152 Table 105: Neurology Devices Market Pipeline Products ........................................................................................................165 Table 106: Vycor Medical Completes Acquisition Of NovaVision ..........................................................................................166 Table 107: VELUX STIFTUNG Acquires Minority Stake In NeMoDevices ...........................................................................167 Table 108: NeuroWave Enters Into Distribution Agreement With CareFusion ....................................................................168 Table 109: Laboratorios Rubio Enters Into Distribution Agreement With AB-Biotics..........................................................169 Table 110: USD to Local Currency, Europe, Average Exchange Rate 2003-2010 ...........................................................180

Table of Contents



1.2 List of Figures Figure 1: Neurology Devices, Cross Country Comparison, Revenue ($m), 2003-2017 ......................................................14 Figure 2: Neurology Devices, Europe, Overall Revenue ($m), 2003-2017 ............................................................................15 Figure 3: Neurology Devices, Europe, Cross-Category Analysis, 2003-2017 ............................................................................16 Figure 4: Neurology Devices, Europe, Overall Revenue ($m), Historic, 2003-2010.............................................................17 Figure 5: Neurology Devices, Europe, Overall Revenue ($m), Forecast, 2010-2017 ..........................................................19 Figure 6: Neurology Devices, Europe, Category Volume (Units), 2003-2017........................................................................21 Figure 7: Neurology Devices, Europe, Category Volume (Units), Historic, 2003-2010 ........................................................22 Figure 8: Neurology Devices, Europe, Category Volume (Units), Forecast, 2010-2017......................................................24 Figure 9: Neurology Devices, Europe, Company share (%), 2010 ..........................................................................................26 Figure 10: Neurology Devices, Germany, Overall Revenue ($m), 2003-2017 ......................................................................28 Figure 11: Neurology Devices, Germany, Overall Revenue ($m), Historic, 2003-2010.......................................................30 Figure 12: Neurology Devices, Germany, Overall Revenue ($m), Forecast, 2010-2017 ....................................................32 Figure 13: Neurology Devices, Germany, Category Volume (Units), 2003-2017..................................................................34 Figure 14: Neurology Devices, Germany, Category Volume (Units), Historic, 2003-2010 ..................................................35 Figure 15: Neurology Devices, Germany, Category Volume (Units), Forecast, 2010-2017................................................37 Figure 16: Neurology Devices, Germany, Company Share (%), 2010 ....................................................................................42 Figure 17: CSF Management, Germany, Company Share (%), 2010 .....................................................................................44 Figure 18: Interventional Neurology, Germany, Company Share (%), 2010..........................................................................46 Figure 19: Neurological Diagnostic Equipment, Germany, Company Share (%), 2010.......................................................48 Figure 20: Neurostimulation Devices, Germany, Company Share (%), 2010 ........................................................................50 Figure 21: Neurosurgical Products, Germany, Company Share (%), 2010............................................................................51 Figure 22: Neurology Devices, France, Overall Revenue ($m), 2003-2017...........................................................................53 Figure 23: Neurology Devices, France, Overall Revenue ($m), Historic, 2003-2010...........................................................55 Figure 24: Neurology Devices, France, Overall Revenue ($m), Forecast, 2010-2017 ........................................................57 Figure 25: Neurology Devices, France, Category Volume (Units), 2003-2017......................................................................59 Figure 26: Neurology Devices, France, Category Volume (Units), Historic, 2003-2010 ......................................................60 Figure 27: Neurology Devices, France, Category Volume (Units), Forecast, 2010-2017 ....................................................62 Figure 28: Neurology Devices, France, Company Share (%), 2010 ........................................................................................67 Figure 29: CSF Management, France, Company Share (%), 2010 .........................................................................................69 Figure 30: Interventional Neurology, France, Company Share (%), 2010 ..............................................................................71 Figure 31: Neurological Diagnostic Equipment, France, Company Share (%), 2010...........................................................73 Figure 32: Neurostimulation Devices, France, Company Share (%), 2010 ............................................................................75 Figure 33: Neurosurgical Products, France, Company Share (%), 2010................................................................................77 Figure 34: Neurology Devices, United Kingdom, Overall Revenue ($m), 2003-2017 ..........................................................79 Figure 35: Neurology Devices, United Kingdom, Overall Revenue ($m), Historic, 2003-2010...........................................81 Figure 36: Neurology Devices, United Kingdom, Overall Revenue ($m), Forecast, 2010-2017 ........................................83 Figure 37: Neurology Devices, United Kingdom, Category Volume (Units), 2003-2017......................................................85 Figure 38: Neurology Devices, United Kingdom, Category Volume (Units), Historic, 2003-2010 ......................................86

Table of Contents



Figure 39: Neurology Devices, United Kingdom, Category Volume (Units), Forecast, 2010-2017....................................88 Figure 40: Neurology Devices, United Kingdom, Company Share (%), 2010........................................................................93 Figure 41: CSF Management, United Kingdom, Company Share (%), 2010.........................................................................95 Figure 42: Interventional Neurology, United Kingdom, Company Share (%), 2010..............................................................96 Figure 43: Neurological Diagnostic Equipment, United Kingdom, Company Share (%), 2010...........................................98 Figure 44: Neurostimulation Devices, United Kingdom, Company Share (%), 2010..........................................................100 Figure 45: Neurosurgical Products, United Kingdom, Company Share (%), 2010..............................................................101 Figure 46: Radiosurgery, United Kingdom, Company Share (%), 2010................................................................................102 Figure 47: Neurology Devices, Italy, Overall Revenue ($m), 2003-2017..............................................................................103 Figure 48: Neurology Devices, Italy, Overall Revenue ($m), Historic, 2003-2010 ..............................................................105 Figure 49: Neurology Devices, Italy, Overall Revenue ($m), Forecast, 2010-2017............................................................107 Figure 50: Neurology Devices, Italy, Category Volume (Units), 2003-2017 .........................................................................109 Figure 51: Neurology Devices, Italy, Category Volume (Units), Historic, 2003-2010 .........................................................110 Figure 52: Neurology Devices, Italy, Category Volume (Units), Forecast, 2010-2017 .......................................................112 Figure 53: Neurology Devices, Italy, Company Share (%), 2010 ...........................................................................................117 Figure 54: CSF Management, Italy, Company Share (%), 2010 ............................................................................................119 Figure 55: Interventional Neurology, Italy, Company Share (%), 2010 .................................................................................121 Figure 56: Neurological Diagnostic Equipment, Italy, Company Share (%), 2010 ..............................................................123 Figure 57: Neurostimulation Devices, Italy, Company Share (%), 2010 ...............................................................................125 Figure 58: Neurosurgical Products, Italy, Company Share (%), 2010 ...................................................................................126 Figure 59: Radiosurgery, Italy, Company Share (%), 2010 .....................................................................................................127 Figure 60: Neurology Devices, Spain, Overall Revenue ($m), 2003-2017...........................................................................128 Figure 61: Neurology Devices, Spain, Overall Revenue ($m), Historic, 2003-2010 ...........................................................130 Figure 62: Neurology Devices, Spain, Overall Revenue ($m), Forecast, 2010-2017.........................................................132 Figure 63: Neurology Devices, Spain, Category Volume (Units), 2003-2017 ......................................................................134 Figure 64: Neurology Devices, Spain, Category Volume (Units), Historic, 2003-2010 ......................................................135 Figure 65: Neurology Devices, Spain, Category Volume (Units), Forecast, 2010-2017 ....................................................137 Figure 66: Neurology Devices, Spain, Company Share (%), 2010 ........................................................................................142 Figure 67: CSF Management, Spain, Company Share (%), 2010 .........................................................................................144 Figure 68: Interventional Neurology, Spain, Company Share (%), 2010 ..............................................................................145 Figure 69: Neurological Diagnostic Equipment, Spain, Company Share (%), 2010 ...........................................................147 Figure 70: Neurostimulation Devices, Spain, Company Share (%), 2010 ............................................................................149 Figure 71: Neurosurgical Products, Spain, Company Share (%), 2010 ................................................................................151 Figure 72: Medtronic, Inc., Company Share (%), Europe Neurology Devices Market, 2010 ............................................153 Figure 73: St. Jude Medical, Inc., Company Share (%), Europe Neurology Devices Market, 2010 ................................154 Figure 74: B. Braun Melsungen AG, Company Share (%), Europe Neurology Devices Market, 2010 ...........................155 Figure 75: Boston Scientific Corporation, Company Share (%), Europe Neurology Devices Market, 2010 ..................156 Figure 76: Cadwell Laboratories, Inc., Company Share (%), Europe Neurology Devices Market, 2010 ........................157 Figure 77: Accuray Incorporated, Company Share (%), Europe Neurology Devices Market, 2010 ................................158

Introduction



2 Intr oduction GlobalData’s Med ical E quipment Mark et Rep orts are the i deal guide for anyo ne wishing to understand their market better in terms of revenues, unit sales, distributors and competitors.

2.1 What is This Report About?

The Europe neu rology de vices ma rket report provides an o verview of the n eurology devices market in Europe a nd a lso the fo llowing infor mation re lated to the market and the companies present in the market:

1. Comprehensive d ata related to th e mark et revenue, u nit s ale, company s hare and distribution share.

2. Profiles of key c ompanies op erating i n the E urope neurology devices de vices market, which includes a brief overview of the company. The selection of the companies is based on their operational presence in Europe; it includes key multinationals as well as key local players.

3. A list of key products under development by different companies. The selection of this list is based on the territory in which these products are being clinically investigated.

Note: “ Europe” i ncludes the follo wing countries – Ger many, Fr ance, Italy, United Kin gdom and Spain.

Neurology Devices in Europe



3 Neurology Devices in Europe

3.1 Neurology Devices Cross Country Comparison, Revenue ($m), 2003-2017

Figure 1: Neurology Devices, Cross Country Comparison, Revenue ($m), 2003-2017

Germany

United Kingdom

France

Italy

Spain

Cat

egor

y

Revenue ($m)

2003 2010 2017

Source: GlobalData

Table 1: Neurology Devices, Cross Country Comparison, Revenue ($m), 2003-2017

Country Name 2003 2010 2017 CAGR 03-10 CAGR 10-17 CAGR 03-17

Germany

United Kingdom

France

Italy

Spain

Source: GlobalData




3.2 Neurology Devices, Europe, Overall Revenue ($m), 2003-2017

Figure 2: Neurology Devices, Europe, Overall Revenue ($m), 2003-2017

NeurostimulationDevices

InterventionalNeurology

NeurologicalDiagnostic Equipment

CSF Management

Radiosurgery

NeurosurgicalProducts

Cat

egor

y

Revenue ($m)

2003 2010 2017

Source: GlobalData

Table 2: Neurology Devices, Europe, Overall Revenue ($m), 2003-2017

Category 2003 2010 2017 CAGR 03-10 CAGR 10-17 CAGR 03-17Neurostimulation Devices

Interventional Neurology

Neurological Diagnostic Equipment

CSF Management

Radiosurgery

Neurosurgical Products

Total

Source: GlobalData




Figure 4: Neurology Devices, Europe, Overall Revenue ($m), Historic, 2003-2010

2003 2004 2005 2006 2007 2008 2009 2010

Rev

enue

($m

)

Neurostimulation Devices Interventional NeurologyNeurological Diagnostic Equipment CSF ManagementRadiosurgery Neurosurgical Products

Source: GlobalData




Table 4: Neurology Devices, Europe, Overall Revenue ($m), Historic, 2003-2010

Category 2003 2004 2005 2006 2007 2008 2 009 201 0 CAGR

Neurostimulation Devices

% Growth


% Growth


% Growth

CSF Management

% Growth

Radiosurgery

% Growth


% Growth

Total

% Growth

Source: GlobalData




Figure 5: Neurology Devices, Europe, Overall Revenue ($m), Forecast, 2010-2017

2010 2011 2012 2013 2014 2015 2016 2017

Rev

enue

($m

)

Neurostimulation Devices Interventional NeurologyNeurological Diagnostic Equipment CSF ManagementNeurosurgical Products Radiosurgery

Source: GlobalData




Table 5: Neurology Devices, Europe, Overall Revenue ($m), Forecast, 2010-2017

Category 2010 2011 2012 2013 2014 2015 2 016 2 017 CAGR

Neurostimulation Devices

% Growth


% Growth


% Growth

CSF Management

% Growth


% Growth

Radiosurgery

% Growth

Total

% Growth

Source: GlobalData




3.4 Neurology Devices, Europe, Company share (2009-2010)

Figure 9: Neurology Devices, Europe, Company share (%), 2010

Medtronic, Inc. St. Jude Medical, Inc.B. Braun Melsungen AG Boston Scientific CorporationCadwell Laboratories, Inc. Accuray IncorporatedDePuy, Inc. Terumo CorporationCovidien plc Cyberonics, Inc.Micrus Endovascular Corporation CareFusion CorporationIntegra LifeSciences Holdings Corporation Elekta ABNihon Kohden Corporation Micromed S.p.Aev3 Inc. Natus Medical IncorporatedOthers

Note: Company Share estimates are based on company reports, secondary research and primary researchSource: GlobalData




Table 9: Neurology Devices, Europe, Company share by Revenue ($m), 2009-2010

Company Name 2009 2 010

Medtronic, Inc.

St. Jude Medical, Inc.

B. Braun Melsungen AG

Boston Scientific Corporation

Cadwell Laboratories, Inc.

Accuray Incorporated

DePuy, Inc.

Terumo Corporation

Covidien plc

Cyberonics, Inc.

Micrus Endovascular Corporation

CareFusion Corporation

Integra LifeSciences Holdings Corporation

Elekta AB

Nihon Kohden Corporation

Micromed S.p.A

ev3 Inc.

Natus Medical Incorporated

Others

Total

Source: GlobalData

Overview of Key Companies


© GlobalData. This report is a licensed product and is not to be photocopied Page 153

9 Overview of Key Companies in Europe Neurology Devices Market

9.1 M edtronic, Inc. 9.1.1 Company Overview Medtronic, Inc. (Medtronic) is a medical technology company engaged in the development, manufacture and marketing of a wide range of medical devices, therapies and services used to treat c hronic conditions such as hea rt dis ease, s pinal c onditions, neur ological disorders, vascular disease and diabetes. It op erates in seven business segments namely, Cardiac Rhythm Disease Management (CRDM), Spinal Segment, Cardio Vascular s egment, Neuromodulation s egment, Diab etes segment, Sur gical Tec hnologies s egment an d Physio-Control segment. The company's research and development ac tivities are principally into research, engineering and t echnical efforts for de veloping a ne w p roduct or s ervices a nd to mak e s ignificant improvement to an existing product or manufacturing process. The company principally operates in the US, Europe and Asia-Pacific. It serves physicians, patients and clinicians in over 120 countries around the world. Medtronic is headquartered in Minnesota, the US. The company reported revenues of (U.S. Dollars) USD 15,817.00 million during the fiscal year ended April 2010, an increase of 8.34% over 2009. The operating profit of the company was USD 3,969.00 million during the fiscal year 2 010, an increase of 62.66% over 2009. The net profit o f the company was USD 3,099.00 million during the fiscal year 2010, an increase of 49.71% over 2009.

9.1.2 Share in the Europe Neurology Devices Market

Figure 72: Medtronic, Inc., Company Share (%), Europe Neurology Devices Market, 2010

Others11.1%

Medtronic, Inc.

Note: Company Share estimates are based on company reports, secondary research and primary research Source: GlobalData

Neurology Devices Market Pipeline Products



10 Neurology Devices Market Pipeline Products

Table 105: Neurology Devices Market Pipeline Products Product Name Company/University Name Equipment Type Territory

3T MRI Safe Lead Cyberonics, Inc. Vagus Nerve Stimulators Global

3WiN SYNAPSE Deep Brain Stimulation - Dystonia 3WIN nv Deep Brain Stimulators Europe

3WiN SYNAPSE Deep Brain Stimulation - Parkinson's Disease 3WIN nv Deep Brain Stimulators Europe

Source: GlobalData

Appendix



13 Appendix

The data and analysis within this report is driven by Medical eTrack

Medical eTrack gives you the key information to drive sales, investment and deal making activity in your business. It includes the following information:

14,000+ Market size d ata tables across 4 00 medical eq uipment segments a nd 3 7 c ountries w ith historic data from 2000 forecast to 2016

3,000+ Primary expert interviews conducted for ensuring data and report quality

1,000+ Conferences on medical equipment covered

1,000+ In dustry lea ding r eports c overing growing s ectors, mark et t rends, investment o pportunities and competitive landscape

450+ Analysis reports covering market and pipeline product analysis reports by indication, medical equipment trends and issue reports and investment and M&A trend reports worth over $3 Million

20,000+ Medical equipment companies profiled

1,500+ Private, emerging and technology start-up company profiles

1,000+ Medical equipment manufacturers in China and India

1,500+ Medical equipment companies in Japan

450+ Companies with revenue splits and market shares by category

500+ Quarterly and annual medical equipment company financials

400+ Medical equipment company SWOT’s

7,000+ Pipeline product profiles

4 ,000+ Marketed product profiles

1 ,500+ Pipeline technologies

10,500+ Clinical trials

12,000+ Trial investigators

9,000+ New product patents

2,500+ Companies with products in development

12,000+ Deals in the medical equipment industry

1,100+ Surgical and diagnostic procedures by therapy area

40+ Key healthcare indicators by country

o For more information or to receive a free demo of the service visit

http://www.medicaletrack.com/contactus.aspx?RD=Demo=

Appendix



13.1 Definitions of Markets Covered in the Report

13.1.1 Neurology Devices

Neurology Devices are specialized surgical devices used for the t reatment of disease or condition of the C entral Ne rvous System (CNS) and s pine. Th e n eurology d evices mar ket includes CSF management, radio surgical, neurosurgical, neurostimulation and neurointerventional devices.

13.1.1.1 CSF Management

Cerebro Spin al Fl uid (CSF) ma nagement inc ludes de vices used to impr ove th e mov ement and monitor c erebrospinal fluid. This ma rket c omprises of h ydrocephalus s hunts a nd in tracranial pressure monitoring devices.

13.1.1.2 Interventional Neurology

Interventional neurology includes devices for the treatment of intracranial aneurysms. This market includes devices for the treatment and navigation instruments for the required procedures to treat aneurysms.

13.1.1.3 Neurostimulation Devices

This category includes devices used for the electrical stimulation of specific nerves in the body for a controlled and a de sired result. The devices include a pacemaker for generation of the electric signal and electrodes. External neuro stimulators are not tracked under this market.

13.1.1.4 Neurosurgical Products

Neuro s urgical prod ucts are specialized s urgical devices us ed fo r performing the min imally invasive neurosurgical procedure.

13.1.1.5 Radiosurgery

Radio surgery is a medical procedure which allows non-invasive brain surgery for the in tracranial lesion.

Note: 1) Value, dis tribution and company shares figures re flect annual gr oss sales of n eurology devices in lo cal cu rrency converted to $ a t a ctual rates. Volume figures reflect th e a nnual u nit sales of n eurology d evices. The an nual gr owth ( year on y ear growth) and c ompounded annual growth rate (CAGR) in tables is rounded off to one decimal place.

2) Company share data represents market share (in revenues and as percentage to total market) of companies in market categories and geographies tracked in the da tabase. The data ha s been rounded off to the nearest decimal places.

Appendix



13.2 Resea rch Methodology GlobalData’s dedicated Research and Analysis Teams consist of experienced professionals with a pedigree in marketing, ma rket research a nd c onsulting i n t he medical devices i ndustry with advanced statistical expertise.

GlobalData adheres to the Codes of Practice of the Market Research Society (www.mrs.org.uk) and the Society of Competitive Intelligence Professionals (www.scip.org).

All GlobalData databases are continuously updated and revised.

13.3 Sec ondary Research The re search process b egins w ith exhaustive s econdary research on i nternal and external sources being carried out to source qualitative and quantitative information relating to each market.

The secondary research sources that are typically referred to include, but are not limited to:

Company websites, annual reports, financial reports, broker reports, investor presentations and SEC Filings.

Industry trade journals, scientific journals and other technical literature.

Internal and external proprietary databases.

Relevant patent and regulatory databases.

National government documents, statistical databases and market reports.

Pro cedure registries.

News articles, press releases and web-casts specific to the companies operating in the market.

Appendix



13.4 Prima ry Research GlobalData c onducts hu ndreds of prima ry interviews a yea r w ith in dustry p articipants and commentators in o rder t o v alidate its da ta a nd analysis. A typical r esearch inte rview fulfills t he following functions:

It p rovides first-hand information on th e mar ket s ize, market tren ds, g rowth trends, competitive landscape, future outlook etc.

Helps in validating and strengthening the secondary research findings.

Further develops the Analysis Team’s expertise and market understanding.

o Primary research involves E-mail interactions, telephonic interviews as well as face -to-face interviews for each market, category, segment and sub-segment across geographies.

o The participants who typically take part in such a process include, but are not limited to:

Industry participants: CEOs, VPs, marketing/product managers, market intelli gence manage rs and national sales managers.

Hospital purchasing managers, laboratory personnel, pharmacists, distributors and para-medics.

Outside experts: Investment Bankers, Valuation Experts, Research Analysts specializing in specific medical equipment markets.

Key O pinion L eaders: Physicians an d surgeons s pecializing i n di fferent t herapeutic areas corresponding to different kinds of medical equipment.

13.5 M odels Where no har d data is available GlobalData us es modeling and estimates in order to produce comprehensive data sets. A rigorous methodology is adopted in which the available hard data is cross referenced with the following data types to produce estimates:

Demographic data: Population, split by segment.

Macro-economic Indicators: GDP, Inflation Rate etc.

Healthcare Indicators: Health expenditure, Physicians Base, healthcare infrastructure and facilities.

Selected epidemiological and procedure statistics.

Data is then cross checked by the expert panel. All data and as sumptions r elating to m odeling are stored and are available to clients on request.

Appendix



13.6 Fo recasts GlobalData uses propr ietary forecast mo dels. The following four f actors are uti lized in the forecast models:

Historic growth rates

Macro indicators such as population trends and healthcare spending

Fo recast epidemiological data

Qualitative trend information and assumptions

Data is then cross checked by the Expert Panel.

13.7 Expert Panels GlobalData uses a panel of experts to cross verify its databases and forecasts.

GlobalData expert panel comprises of marketing managers, product specialists, international sales managers fro m me dical de vice c ompanies; a cademics from research universities, KOLs fro m hospitals, consultants f rom venture capital funds and distributors/suppliers of medical equipment and supplies etc.

Historic data and forecasts are relayed to GlobalData’s Expert Panel for feedback and adjusted in accordance with their feedback.

Details of t he m ake u p of t he e xpert pa nel can be v iewed t hrough G lobalData.com an d a re available to clients on request.

13.8 GlobalData Consulting We h ope that th e d ata and analysis in this br ief will he lp you mak e informed and imaginative business decisions. If you have further requirements, GlobalData’s consulting team may be able to help y ou. G lobalData offers Tailor -made analytical a nd adv isory s ervices to d rive your k ey strategic decisions.

Appendix



13.9 Cu rrency Conversion

Table 110: USD to Local Currency, Europe, Average Exchange Rate 2003-2010

Country Currency Conversion Rate

200 3 200 4 2005 2006 2007 2008 2009 2010

Germany EUR 0.885 0 .805 0.804 0.797 0.731 0.683 0 .719 0.755

France EUR 0.885 0 .805 0.804 0.797 0.731 0.683 0 .719 0.755

United Kingdom GBP 0.612 0.546 0.550 0.543 0.500 0.545 0.641 0.647

Italy EUR 0.885 0 .805 0.804 0.797 0.731 0.683 0 .719 0.755

Spain EUR 0.885 0 .805 0.804 0.797 0.731 0.683 0 .719 0.755

Source: GlobalData

13.11 Di sclaimer All Rights Reserved.

No part of t his publication may be reproduced, s tored in a retrieval system or transmitted in any form by any means, electronic, mechanical, photocopying, recording or otherwise without the prior permission of the publisher, GlobalData.

gdme0059rdb europe neurology devices market outlook to 2017 · 4.3.5 neurosurgical products,...

Documents